Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study

Bioactive Glass (S53P4) as Bone Graft Substitute in Operative Treatment of Depressed Lateral Condyle Fractures, Benign Bone Tumour Cavities and in Spinal Fusion - a 10 Years Follow-up and Bone Density Study.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00935870

Enrollment

Registered

2009-07-09

Start date

2008-01-31

Completion date

2009-02-28

Last updated

2009-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Bone Tumour Cavity, Depressed Lateral Condyle Fracture, Spinal Fusion

Brief summary

The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.

Interventions

DEVICEBioactive glass and/or autogenous bone

No intervention in the current study (10-year follow-up study)

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Written informed consent obtained; Participation of previous clinical investigation with bioactive glass

Exclusion criteria

* The subject is unlikely to adhere to study procedures * Concurrent disease or condition that in the opinion of the investigator is contraindicating participation * Simultaneous participation in another medical device or investigational drug trial

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026